Evidence map›Paper›PMID 33942847›Full record

ArticleMolecular biology and evolution2021

An Evolutionary Portrait of the Progenitor SARS-CoV-2 and Its Dominant Offshoots in COVID-19 Pandemic.

Sudhir Kumar, Qiqing Tao, Steven Weaver, Maxwell Sanderford, Marcos A Caraballo-Ortiz, Sudip Sharma, Sergei L K Pond, Sayaka Miura

Open access · goldAbstract read
In one paragraph

Article in Molecular biology and evolution, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Sudhir KumarInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.ORCID 0000-0002-9918-8212
Qiqing TaoInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.ORCID 0000-0001-7360-409X
Steven WeaverInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.
Maxwell SanderfordInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.
Marcos A Caraballo-OrtizInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.
Sudip SharmaInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.
Sergei L K PondInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.
Sayaka MiuraInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA.
Temple University · USKing Abdulaziz University · SA

Funding

Turning big data analysis infrastructure for HIV researchR01AI134384 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI NEKRUTENKO, ANTON, POND, SERGEI L KOSAKOVSKY · 2017 to 2021
$4.2M
Methods For Evolutionary Genomics AnalysisR35GM139540 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI Sudhir Kumar · 2021 to 2026
$2.9M
Cyclic Flow Cytometry for Ultra-High Marker Single-Cell AnalysisR44GM139504 · NIGMS · LASE INNOVATION INC. · PI KWOK, SHELDON J.J. · 2021 to 2022
$1.7M
Inferring molecular evolutionary rates and divergence datesR01GM126567 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI KUMAR, SUDHIR · 2018 to 2020
$951k
Cyclic Flow Cytometry for Ultra-High Marker Single-Cell AnalysisR43GM139504 · NIGMS · LASE INNOVATION INC. · PI KWOK, SHELDON J.J. · 2020 to 2020
$252k
NIAID NIH HHS R01 AI134384NIGMS NIH HHS R01 GM126567NIGMS NIH HHS R35 GM139540NIGMS NIH HHS R43 GM139504NIGMS NIH HHS R44 GM139504
6 · The paper itself

Abstract

Global sequencing of genomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to reveal new genetic variants that are the key to unraveling its early evolutionary history and tracking its global spread over time. Here we present the heretofore cryptic mutational history and spatiotemporal dynamics of SARS-CoV-2 from an analysis of thousands of high-quality genomes. We report the likely most recent common ancestor of SARS-CoV-2, reconstructed through a novel application and advancement of computational methods initially developed to infer the mutational history of tumor cells in a patient. This progenitor genome differs from genomes of the first coronaviruses sampled in China by three variants, implying that none of the earliest patients represent the index case or gave rise to all the human infections. However, multiple coronavirus infections in China and the United States harbored the progenitor genetic fingerprint in January 2020 and later, suggesting that the progenitor was spreading worldwide months before and after the first reported cases of COVID-19 in China. Mutations of the progenitor and its offshoots have produced many dominant coronavirus strains that have spread episodically over time. Fingerprinting based on common mutations reveals that the same coronavirus lineage has dominated North America for most of the pandemic in 2020. There have been multiple replacements of predominant coronavirus strains in Europe and Asia as well as continued presence of multiple high-frequency strains in Asia and North America. We have developed a continually updating dashboard of global evolution and spatiotemporal trends of SARS-CoV-2 spread (http://sars2evo.datamonkey.org/).

Indexed as

Biological EvolutionComputational BiologyContact TracingCOVID-19Evolution, MolecularGenome, ViralHumansMutationPandemicsPhylogenySARS-CoV-2Sequence Analysis, DNAcoronavirusphylogenyweb tool

Identifiers

PMID33942847
PMCPMC8135569
OpenAlexW3158268380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.